{
    "code": "02017380",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02017380",
    "time": "2022-02-18 07:36:45",
    "許可證字號": "衛署藥輸字第017380號",
    "註銷狀態": "已註銷",
    "註銷日期": "110\/12\/24",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "",
    "有效日期": "108\/11\/04",
    "發證\/登錄日期": "78\/08\/16",
    "許可證種類": "製　劑",
    "舊證字號": "02009417",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00201738005",
    "中文品名": "碧露眼藥水",
    "英文品名": "MARINEEYE-A",
    "適應症": "暫時緩解因輕微眼部刺激所引起之不適、眼睛紅、眼睛癢、眼睛疲勞。",
    "劑型": "472點眼液劑",
    "包裝": "瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "17醫師藥師藥劑生指示藥品",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CHLORPHENIRAMINE MALEATE, NAPHAZOLINE HCL, CHONDROITIN SULFATE SODIUM (EQ TO SODIUM CHONDROITIN SULFATE )",
    "限制項目": "02輸　入 1Q不得輸入",
    "申請商名稱": "1224802100  順仁西藥行",
    "申請商地址": "新北市中和區中山路二段３１２巷１２號１Ｆ",
    "主製造廠": [
        {
            "": "JAPAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0400000810",
            "成分名稱": "CHLORPHENIRAMINE MALEATE",
            "含量描述": "0.10",
            "含量": "0.1000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1212001910",
            "成分名稱": "NAPHAZOLINE HCL",
            "含量描述": "0.03",
            "含量": "0.0300000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2406000310",
            "成分名稱": "CHONDROITIN SULFATE SODIUM (EQ TO SODIUM CHONDROITIN SULFATE )",
            "含量描述": "3.00",
            "含量": "3.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "020173800003-104-09-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02017380&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "020173800001-104-09-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02017380&Seq=005&Type=9"
        },
        {
            "title": "020173800002-104-09-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02017380&Seq=004&Type=8"
        }
    ]
}